(Q43054632)

English

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma.

scientific article published in June 2010

Statements

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit